Introduction:
Some pharma stocks are trading below their book value. This could mean they are undervalued. In this article, we list a few such companies with a price-to-book value of less than 1.
Price-to-book value compares a company’s market price with its book value. A value under 1 means the stock is priced lower than its net assets. Here are some pharma stocks that meet this criterion.
Also Read: Upcoming IPOs: Sawaliya Foods and 8 others coming up with IPOs next week
Dishman Carbogen Amcis
On August 1, 2025, Dishman Carbogen Amcis Ltd opened at ₹251.10, down 0.34% from its previous close of ₹251.95. The stock reached a high of ₹252.00 and a low of ₹243.00. By 4:00 PM, it closed at ₹244.85, marking a 2.82% decline, with a market cap of ₹3,838.83 crore.
Dishman Carbogen Amcis has a price-to-book value of 0.66, indicating it trades below its book value. Its low debt-to-equity ratio of 0.41 reflects a relatively stable financial position.
Dishman Carbogen Amcis Ltd provides Contract Research and Manufacturing Services (CRAMS) and produces specialty chemicals, vitamins, and disinfectants. It operates across Europe, China, and other global markets. (NSE Symbol: DCAL)
Mangalam Drugs
On August 1, 2025, Mangalam Drugs & Organics Ltd opened at ₹87.50, down 1.52% from its previous close of ₹88.85. The stock touched a high of ₹89.18 and a low of ₹87.27. By 4:00 PM, it closed at ₹88.19, marking a 0.74% decline, with a market cap of ₹139.59 crore.
Mangalam Drugs and Organics Ltd has a price-to-book value of 0.94, trading below book value. Its debt-to-equity ratio stands at 0.60, suggesting a moderately low financial leverage.
Mangalam Drugs and Organics Ltd, incorporated in 1977, manufactures APIs, bulk drugs, and chemicals. It supplies WHO-approved anti-malarial ingredients and partners with the Clinton Foundation. (NSE Symbol: MANGALAM)
Also Read: Green energy stock under ₹70 jumps 8% after receiving order from Zelestra
Natural Capsules
On August 1, 2025, Natural Capsules Ltd opened at ₹211.55, down 0.98% from its previous close of ₹213.65. The stock reached a high of ₹218.10 and a low of ₹209.35. By 4:00 PM, it closed at ₹214.00, up 0.16%, with a market cap of ₹221.30 crore.
Natural Capsules Ltd has a price-to-book value of 0.95, indicating it trades below its book value. With a debt-to-equity ratio of 0.45, the company maintains low financial leverage.
Natural Capsules Ltd (NSE: NATCAPSUQ), incorporated in 1993, manufactures gelatin and cellulose capsules for pharma and nutraceutical use. It also produces steroidal APIs through its subsidiary, Natural Biogenex Pvt. Ltd.
Stay Ahead with the Latest Stock Market Updates – Click Here
Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.
